Pelvic physiotherapy in a patient infected with human T-cell lymphotropic virus type 1: A case report
DOI:
https://doi.org/10.33233/fb.v23i4.4930Keywords:
human T-lymphotropic virus 1, urinary bladder, neurogenic, pelvic physiotherapyAbstract
Introduction: Human T-cell lymphotropic virus type 1 (HTLV-1) is the etiological agent of Tropical Spastic Paraparesis/HTLV-1-associated myelopathy that causes the individual to present motor, sensory and urinary tract dysfunction impairments. Methods: A 58-year-old female patient, resident of Belém/PA, with clinical diagnosis of tropical spastic paraparesis associated with human T-cell lymphotropic virus type 1 (HTLV-1) and Parkinson's disease, presented dysfunctional neurogenic bladder, and performed 10 sessions of a physiotherapeutic protocol. Results: The intervention protocol positively affected the patient's quality of life, with a decrease in the score values of 6 domains evaluated by the King's Health questionnaire and in the urinary symptoms reported by the patient. Conclusion: The results suggest that pelvic physiotherapy is a viable option in improving the quality of life of patients with neurogenic bladder.
References
Brasil. Ministério da Saúde. Guia do manejo clínico do HTLV [Internet]. Brasília: Ministério da Saúde; 2013. [cited 2022 June 30]. Available from: http://www.sierj.org.br/artigos/htlv_manual_final_pdf_25082.pdf
Romanelli LCF, Caramelli P, Proietti ABdFC. O vírus linfotrópico de células T humanos tipo 1 (HTLV-1): Quando suspeitar da infecção? Revista da Associação Médica Brasileira 2010;56:340-7. doi: 10.1590/s0104-42302010000300021
Brites C, Grassi MF, Quaresma JAS, Ishak R, Vallinoto ACR. Patogênese da infecção HTLV-1 e biomarcadores de progressão: Uma visão geral. Revista Brasileira de Doenças Infecciosas 2021;25. doi: 10.1016/j.bjid.2021.101594
Oliveira P, Castro NM, Muniz AL, Tanajura D, Brandão JC, Porto AF, et al. Prevalence of erectile dysfunction in HTLV-1–infected patients and its association with overactive bladder. Urology 2010;75(5):1100-3. doi: 10.1016/j.urology.2009.11.041
Castro NM, Rodrigues Jr W, Freitas DM, Muniz A, Oliveira P, Carvalho EM. Urinary symptoms associated with human T-cell lymphotropic virus type I infection: evidence of urinary manifestations in large group of HTLV-I carriers. Urology 2007;69(5):813-8. doi: 10.1016/j.urology.2007.01.052
Gascón MRP, Mellão MA, Mello SH, Negrão RM, Casseb J, Oliveira ACP. O impacto da incontinência urinária na qualidade de vida e na sexualidade de pacientes com HAM/TSP. Revista Brasileira de Doenças Infecciosas 2018;22:288-93. doi: 10.1016/j.bjid.2018.07.003
Andrade R, Tanajura D, Santana D, Santos Dd, Carvalho EM. Association between urinary symptoms and quality of life in HTLV-1 infected subjects without myelopathy. Int Braz J Urol 2013;39:861-6. doi: 10.1590/s1677-5538.ibju.2013.06.13
Andrade RC, Neto JA, Andrade L, Oliveira TS, Santos DN, Oliveira CJ, et al. Efeitos da fisioterapia no tratamento da bexiga neurogênica em pacientes infectados com vírus linfotrópico humano 1. Urologia 2016;89:33-9. doi: 10.1016/j.urology.2015.09.036
Fischer-Sgrott FO, Manffra EF, Busato Junior WF. Qualidade de vida de mulheres com bexiga hiperativa refratária tratadas com estimulação elétrica do nervo tibial posterior. Braz J Phys Ther 2009;13:480-6. doi: 10.1590/s1413-35552009000600003
Fonseca ESM, Camargo ALM, Castro RA, Sartori MGF, Fonseca MCM, Lima GR, et al. Validation of a quality of life questionnaire (King's Health Questionnaire) in Brazilian women with urinary incontinence. Revista Brasileira de Ginecologia e Obstetrícia 2005;27(5):235-42. doi: 10.1590/s0100-72032005000500002
Tamanini JTN, Dambros M, D'Ancona CAL, Palma PCR, Netto Jr R. Validação para o português do" International Consultation on Incontinence Questionnaire-Short form"(ICIQ-SF). Rev Saúde Pública. 2004;38:438-44. doi: 10.1590/s0034-89102004000300015
Peters KM, Carrico DJ, Perez-Marrero RA, Khan AU, Wooldridge LS, Davis GL, et al. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol 2010;183(4):1438-43. doi: 10.1016/j.juro.2009.12.036
Yamano Y, Sato T. Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis. Front Microbiol 2012;3:389. doi: 10.3389/fmicb.2012.00389
Patrício NA, Vidal DG, Pinto EB, Sá KN, Baptista AF. Efetividade dos jogos de realidade virtual para quedas, oscilações posturais, dor e qualidade de vida do HAM/TSP individual: um ensaio clínico randomizado, controlado. Revista de NeuroVirologia 2020;26(5):676-86. doi: 10.1007/s13365-020-00880-x
Yamakawa N, Yagishita N, Matsuo T, Yamauchi J, Ueno T, Inoue E, et al. Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis. Orphanet J Rare Dis 2020;15(1):1-11. doi: 10.1186/s13023-020-01451-3
Andrade RCP. Fisioterapia pélvica em infectados pelo HTLV-1 com disfunção vésico-uretra [Tese] [Internet]. [cited 2022 June 30]. Available from: http://repositorio.ufba.br/ri/handle/ri/22049
Iijima N, Yamauchi J, Yagishita N, Araya N, Aratani S, Tanabe K, et al. Clinical course of neurogenic bladder dysfunction in human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: a nationwide registry study in Japan. Orphanet J Rare Dis 2021;16(1):1-10. doi: 10.1186/s13023-021-01990-3
Published
Issue
Section
License
Copyright (c) 2022 Clicia Raiane Galvão Ferreira, Wenderk Martins Soares, Ana Beatríz Coutinho Sousa, Elizabeth Bonfim Bernardo, Cibele Nazaré Câmara Rodrigues, Denise da Silva Pinto
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are authorized for non-exclusive distribution of the version of the work published in this journal (eg, publishing in an institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
